ActiGraph Digital Data Summit 2025
February 10-12 | Pensacola Beach, FL
Crossing the Chasm: The Digital Transformation of Clinical Research
The ActiGraph Digital Data Summit 2025 is a one-of-a-kind event advancing the application of wearable digital health technology (DHT) in clinical research. Together, we can address opportunities and challenges facing broader adoption of digital measures in drug development.
It takes collaboration across the multidisciplinary field of digital health to accelerate the translation of research to clinical application and realize the potential of delivering more effective treatments to patients faster. We invite scientists, public health researchers, clinicians, regulators, and technology experts to join ADDS and drive change together.
ADDS 2025 Keynote and Featured Speakers
-
Brian Caulfield
Professor of Physiology, PI and Founding Director,
INSIGHT Centre for Data AnalyticsUniversity College Dublin
-
Tina Duong PT, PhD
Physical Therapist, Sr. Research Scientist,
Director or Clinical Outcomes Research and DevelopmentStanford University
Division of Neuromuscular Medicine -
Tim McCarthy
VP and Head of Biomeasures, Endpoints and
Study TechnologiesPfizer
-
Daniel Lachant, DO
Assistant Professor of Medicine
University of Rochester
-
Fernando Vieira
CEO and Chief Scientific Officer
ALS Therapy Development Institute
-
Jennifer Schrack, PhD
Professor of Epidemiology and Director
Center on Aging and Health
at the Johns Hopkins University
-
Brian Caulfield
Professor of Physiology, PI and Founding Director,
INSIGHT Centre for Data AnalyticsUniversity College Dublin
-
Tina Duong PT, PhD
Physical Therapist, Sr. Research Scientist,
Director or Clinical Outcomes Research and DevelopmentStanford University
Division of Neuromuscular Medicine -
Tim McCarthy
VP and Head of Biomeasures, Endpoints and
Study TechnologiesPfizer
-
Daniel Lachant, DO
Assistant Professor of Medicine
University of Rochester
-
Fernando Vieira
CEO and Chief Scientific Officer
ALS Therapy Development Institute
-
Jennifer Schrack, PhD
Professor of Epidemiology and Director
Center on Aging and Health
at the Johns Hopkins University
Check back regularly for new speakers!
Why Attend ADDS 2025?
ADDS is your chance to learn from, network with, and develop collaborations with colleagues from a variety of disciplines, including clinicians, data scientists, clinical trialists, digital health technology specialists, and public health researchers.
Keynote Speakers
Client Case Studies
Panel Discussions
Networking Forums
Scientific Poster Session
Partner Exhibits
ALS Pre-Conference Workshop
Monday, February 10th, 1:00 PM CT
While many have demonstrated the potential of digital measures, there is still a substantial gap to their use as primary or key secondary endpoints in ALS clinical trials. To make progress towards this finish line, ADDS 2025 will include a focused pre-conference workshop with global KOLs in ALS trial design.
Workshop attendees will gather to discuss open research and methodological questions, needs and barriers in ALS clinical development, and current evidence gaps with the goal of developing an action plan, timeline and establish collaborative efforts.
ActiGraph Headquarters Tour
Wednesday, February 12th, 3:30 PM CT
Our team is proud to host the ActiGraph Digital Data Summit in Pensacola Beach, FL, just minutes away from our company headquarters in downtown Pensacola. This year, we’re excited to invite interested ADDS attendees behind-the-scenes!
Join us for a trolley ride through historic downtown Pensacola (the oldest city in America), and then tour the ActiGraph office space. You'll have the opportunity to meet team members and learn more about both our company history and our future as we pioneer the digital transformation of clinical research.
ADDS 2025 Scientific Poster Session
The ADDS 2025 scientific poster session will highlight original research that involves the use of wearable digital health technologies (DHTs). This is an exciting opportunity for researchers to share their work with digital health leaders across academia and the drug development industry! Selected participants will be notified by Monday, November 11, 2024.
What Did Attendees Say About ADDS?
It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.
Ariel Dowling, PhD
Head of Sensing and Measurement | Takeda
It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.
Johathan Soslow
Pediatric Cardiologist | Vanderbuilt University
An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.
Peter Fernandes
CEO | Bellerophon Therapeutics
I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.
Jennifer Schrack, PhD
Professor of Epidemiology and Director | Center on Aging and Health at the Johns Hopkins University